FOLH1 and neoplasm: We recalculated 177Lu-PSMA-617 dosimetry with OLINDA/EXM 2.2.3 based on their kinetics values and obtained results closer to 64Cu-DOTHA2-PSMA, notably 5.43 × 102 mGy/MBq, 3.08 × 102 mGy/MBq, and 5.85 mGy/MBq for tumor, kidneys and liver, respectively.